Shanghai Haoyuan Chemexpress Co. Ltd. A (688131) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.034x

Based on the latest financial reports, Shanghai Haoyuan Chemexpress Co. Ltd. A (688131) has a cash flow conversion efficiency ratio of 0.034x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥107.21 Million ≈ $15.69 Million USD) by net assets (CN¥3.13 Billion ≈ $458.54 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 688131 net asset quality index to measure how much of total assets are equity-financed.

Shanghai Haoyuan Chemexpress Co. Ltd. A - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Shanghai Haoyuan Chemexpress Co. Ltd. A's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 688131 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Shanghai Haoyuan Chemexpress Co. Ltd. A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shanghai Haoyuan Chemexpress Co. Ltd. A ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Migros Ticaret AS
IS:MGROS
0.172x
Autohome Inc
NYSE:ATHM
0.001x
Guangxi Liugong Machinery Co Ltd
SHE:000528
0.011x
Shanghai Tunnel Engineering Co Ltd
SHG:600820
0.135x
Shanghai Kingstar Winning Software
SHE:300253
-0.012x
Now Inc
NYSE:DNOW
-0.044x
Grindwell Norton Limited
NSE:GRINDWELL
0.090x
CoreCivic Inc
NYSE:CXW
0.010x

Annual Cash Flow Conversion Efficiency for Shanghai Haoyuan Chemexpress Co. Ltd. A (2013–2025)

The table below shows the annual cash flow conversion efficiency of Shanghai Haoyuan Chemexpress Co. Ltd. A from 2013 to 2025. For the full company profile with market capitalisation and key ratios, see 688131 stock market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥9.43 Billion
≈ $1.38 Billion
CN¥317.75 Million
≈ $46.50 Million
0.034x -74.37%
2024-12-31 CN¥2.90 Billion
≈ $424.98 Million
CN¥381.96 Million
≈ $55.89 Million
0.132x +633.61%
2023-12-31 CN¥2.53 Billion
≈ $369.67 Million
CN¥-62.27 Million
≈ $-9.11 Million
-0.025x +76.07%
2022-12-31 CN¥2.33 Billion
≈ $341.24 Million
CN¥-240.23 Million
≈ $-35.15 Million
-0.103x -427.11%
2021-12-31 CN¥1.84 Billion
≈ $268.73 Million
CN¥57.83 Million
≈ $8.46 Million
0.031x -85.77%
2020-12-31 CN¥527.81 Million
≈ $77.24 Million
CN¥116.79 Million
≈ $17.09 Million
0.221x +54.98%
2019-12-31 CN¥399.73 Million
≈ $58.49 Million
CN¥57.07 Million
≈ $8.35 Million
0.143x -10.78%
2018-12-31 CN¥177.65 Million
≈ $26.00 Million
CN¥28.43 Million
≈ $4.16 Million
0.160x +72.73%
2017-12-31 CN¥114.74 Million
≈ $16.79 Million
CN¥10.63 Million
≈ $1.56 Million
0.093x +143.20%
2016-12-31 CN¥56.86 Million
≈ $8.32 Million
CN¥-12.19 Million
≈ $-1.78 Million
-0.214x -484.77%
2015-12-31 CN¥32.65 Million
≈ $4.78 Million
CN¥1.82 Million
≈ $266.30K
0.056x +146.55%
2014-12-31 CN¥33.10 Million
≈ $4.84 Million
CN¥-3.96 Million
≈ $-579.94K
-0.120x -197.57%
2013-12-31 CN¥9.70 Million
≈ $1.42 Million
CN¥1.19 Million
≈ $174.12K
0.123x --

About Shanghai Haoyuan Chemexpress Co. Ltd. A

SHG:688131 China Drug Manufacturers - Specialty & Generic
Market Cap
$2.49 Billion
CN¥17.05 Billion CNY
Market Cap Rank
#5448 Global
#981 in China
Share Price
CN¥80.37
Change (1 day)
-0.19%
52-Week Range
CN¥52.65 - CN¥98.11
All Time High
CN¥148.50
About

Shanghai Haoyuan Chemexpress Co., Ltd. researches, develops, and manufactures pharmaceutical intermediates and small molecule drugs. The company offers APIs and API intermediates, vitamin D series compounds, CRO building blocks, and CRO life bioscience compounds. The company was founded in 2006 and is headquartered in Shanghai, China.